| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0007 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |